We prosepctively studied 200,000 newborns to determine the frequency and clinical characteristics of alpha1-antitrypsin deficiency. One hundred and twenty Pi Z, 48 Pi SZ, two PI Z-and one Pi S-infants were identified and followed to the age of six months. Fourteen of 120 Pi Z infants had prolonged obstructive jaundice, nine with severe clinical and laboratory evidence of liver disease. Five had only laboratory evidence of liver disease. Eight other Pi Z infants had minimal abnormalities in serum bilirubin and hepatic enzyme activity and variable hepatosplenomegaly. All 22 Pi Z infants with hepatic abnormalities, two thirds of whom were made, appeared healthy at six months of age. Ninety-eight Pi Z infants did not have clinical liver disease, but liver-function tests gave abnormal results in 44 of 84 at three months, and in 36 of 60 at six months of age. The number of small-for-gestational-age infants was greater (P less than 0.001) among those with clinical liver disease. None of the 48 Pi SZ infants had clinical liver disease, but 10 of 42 at three months and one of 22 at six months of age had abnormal liver function. The Pi Z and Pi SZ phenotypes are associated with covert or readily apparent hepatic dysfunction in the first three months of life.
This article has been cited by other articles:
Hogarth, D. K., Rachelefsky, G.
(2008). Screening and Familial Testing of Patients for {alpha}1-Antitrypsin Deficiency. Chest
133: 981-988
[Abstract][Full Text]
Hidvegi, T., Mirnics, K., Hale, P., Ewing, M., Beckett, C., Perlmutter, D. H.
(2007). Regulator of G Signaling 16 Is a Marker for the Distinct Endoplasmic Reticulum Stress State Associated with Aggregated Mutant {alpha}1-Antitrypsin Z in the Classical Form of {alpha}1-Antitrypsin Deficiency. J. Biol. Chem.
282: 27769-27780
[Abstract][Full Text]
Chang, Y.-P., Mahadeva, R., Chang, W.-S. W., Shukla, A., Dafforn, T. R., Chu, Y.-H.
(2006). Identification of a 4-mer Peptide Inhibitor that Effectively Blocks the Polymerization of Pathogenic Z {alpha}1-Antitrypsin. Am. J. Respir. Cell Mol. Bio.
35: 540-548
[Abstract][Full Text]
Lomas, D. A.
(2006). The Selective Advantage of {alpha}1-Antitrypsin Deficiency. Am. J. Respir. Crit. Care Med.
173: 1072-1077
[Abstract][Full Text]
Strange, C., Moseley, M. A., Jones, Y., Schwarz, L., Xie, L., Brantly, M. L.
(2006). Genetic Testing of Minors for Alpha1-Antitrypsin Deficiency. Arch Pediatr Adolesc Med
160: 531-534
[Abstract][Full Text]
Stoller, J. K., Sandhaus, R. A., Turino, G., Dickson, R., Rodgers, K., Strange, C.
(2005). Delay in Diagnosis of {alpha}1-Antitrypsin Deficiency: A Continuing Problem. Chest
128: 1989-1994
[Abstract][Full Text]
Piitulainen, E., Carlson, J., Ohlsson, K., Sveger, T.
(2005). {alpha}1-Antitrypsin Deficiency in 26-Year-Old Subjects: Lung, Liver, and Protease/Protease Inhibitor Studies. Chest
128: 2076-2081
[Abstract][Full Text]
Schmidt, B. Z., Perlmutter, D. H.
(2005). Grp78, Grp94, and Grp170 interact with {alpha}1-antitrypsin mutants that are retained in the endoplasmic reticulum. Am. J. Physiol. Gastrointest. Liver Physiol.
289: G444-G455
[Abstract][Full Text]
Mahadeva, R., Atkinson, C., Li, Z., Stewart, S., Janciauskiene, S., Kelley, D. G., Parmar, J., Pitman, R., Shapiro, S. D., Lomas, D. A.
(2005). Polymers of Z {alpha}1-Antitrypsin Co-Localize with Neutrophils in Emphysematous Alveoli and Are Chemotactic in Vivo. Am. J. Pathol.
166: 377-386
[Abstract][Full Text]
Lomas, D A, Parfrey, H
(2004). {alpha}1-Antitrypsin deficiency * 4: Molecular pathophysiology. Thorax
59: 529-535
[Abstract][Full Text]
Mulgrew, A. T., Taggart, C. C., Lawless, M. W., Greene, C. M., Brantly, M. L., O'Neill, S. J., McElvaney, N. G.
(2004). Z {alpha}1-Antitrypsin Polymerizes in the Lung and Acts as a Neutrophil Chemoattractant. Chest
125: 1952-1957
[Abstract][Full Text]
Needham, M, Stockley, R A
(2004). {alpha}1-Antitrypsin deficiency * 3: Clinical manifestations and natural history. Thorax
59: 441-445
[Abstract][Full Text]
Lawless, M. W., Greene, C. M., Mulgrew, A., Taggart, C. C., O'Neill, S. J., McElvaney, N. G.
(2004). Activation of Endoplasmic Reticulum-Specific Stress Responses Associated with the Conformational Disease Z {alpha}1-Antitrypsin Deficiency. J. Immunol.
172: 5722-5726
[Abstract][Full Text]
Luisetti, M, Seersholm, N
(2004). {alpha}1-Antitrypsin deficiency {middle dot} 1: Epidemiology of {alpha}1-antitrypsin deficiency. Thorax
59: 164-169
[Abstract][Full Text]
Devlin, G. L., Carver, J. A., Bottomley, S. P.
(2003). The Selective Inhibition of Serpin Aggregation by the Molecular Chaperone, {alpha}-Crystallin, Indicates a Nucleation-dependent Specificity. J. Biol. Chem.
278: 48644-48650
[Abstract][Full Text]
(2003). American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am. J. Respir. Crit. Care Med.
168: 818-900
[Full Text]
Green, C., Brown, G., Dafforn, T. R., Reichhart, J.-M., Morley, T., Lomas, D. A., Gubb, D.
(2003). Drosophila necrotic mutations mirror disease-associated variants of human serpins. Development
130: 1473-1478
[Abstract][Full Text]
Teckman, J. H., An, J.-K., Loethen, S., Perlmutter, D. H.
(2002). Fasting in alpha 1-antitrypsin deficient liver: constitutive activation of autophagy. Am. J. Physiol. Gastrointest. Liver Physiol.
283: G1156-G1165
[Abstract][Full Text]
Piitulainen, E, Sveger, T
(2002). Respiratory symptoms and lung function in young adults with severe {alpha}1-antitrypsin deficiency (PiZZ). Thorax
57: 705-708
[Abstract][Full Text]
Parmar, J. S., Mahadeva, R., Reed, B. J., Farahi, N., Cadwallader, K. A., Keogan, M. T., Bilton, D., Chilvers, E. R., Lomas, D. A.
(2002). Polymers of alpha 1-Antitrypsin Are Chemotactic for Human Neutrophils . A New Paradigm for the Pathogenesis of Emphysema. Am. J. Respir. Cell Mol. Bio.
26: 723-730
[Abstract][Full Text]
Yoon, D, Kueppers, F, Genta, R M, Klintmalm, G B, Khaoustov, V I, Yoffe, B
(2002). Role of alpha-1-antichymotrypsin deficiency in promoting cirrhosis in two siblings with heterozygous alpha-1-antitrypsin deficiency phenotype SZ. Gut
50: 730-732
[Abstract][Full Text]
Carrell, R. W., Lomas, D. A.
(2002). Alpha1-Antitrypsin Deficiency -- A Model for Conformational Diseases. NEJM
346: 45-53
[Full Text]
Canva, V., Piotte, S., Aubert, J.-P., Porchet, N., Lecomte-Houcke, M., Huet, G., Zenjari, T., Roumilhac, D., Pruvot, F.-R., Degand, P., Paris, J.-C., Balduyck, M.
(2001). Heterozygous M3Mmalton {alpha}1-Antitrypsin Deficiency Associated with End-Stage Liver Disease: Case Report and Review. Clin. Chem.
47: 1490-1496
[Abstract][Full Text]
PRIMHAK, R A, TANNER, M S
(2001). Alpha-1 antitrypsin deficiency. Arch. Dis. Child.
85: 2-5
[Full Text]
Mullins, C. D., Huang, X., Merchant, S., Stoller, J. K.
(2001). The Direct Medical Costs of {{alpha}}1-Antitrypsin Deficiency. Chest
119: 745-752
[Abstract][Full Text]
Stoller, J. K., Brantly, M., Fleming, L. E., Bean, J. A., Walsh, J.
(2000). Formation and Current Results of a Patient-Organized Registry for {alpha}1-Antitrypsin Deficiency. Chest
118: 843-848
[Abstract][Full Text]
Hillebrand, G, Schneppenheim, R, Oldigs, H D, Santer, R
(2000). Hereditary fructose intolerance and alpha 1 antitrypsin deficiency. Arch. Dis. Child.
83: 72-73
[Abstract][Full Text]
Yim, J.-J., Park, G. Y., Lee, C.-T., Kim, Y. W., Han, S. K., Shim, Y.-S., Yoo, C.-G.
(2000). Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax
55: 121-125
[Abstract][Full Text]
Teckman, J. H., Gilmore, R., Perlmutter, D. H.
(2000). Role of ubiquitin in proteasomal degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum. Am. J. Physiol. Gastrointest. Liver Physiol.
278: G39-G48
[Abstract][Full Text]
Pahl, H. L.
(1999). Signal Transduction From the Endoplasmic Reticulum to the Cell Nucleus. Physiol. Rev.
79: 683-701
[Abstract][Full Text]
Piitulainen, E., Tornling, G., Eriksson, S.
(1998). Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ). Thorax
53: 939-943
[Abstract][Full Text]
Mahadeva, R., Lomas, D. A
(1998). Genetics and respiratory disease bullet 2: Alpha1-antitrypsin deficiency, cirrhosis and emphysema. Thorax
53: 501-505
[Full Text]
Elliott, P. R., Bilton, D., Lomas, D. A.
(1998). Lung Polymers in Z alpha 1-Antitrypsin Deficiency-related Emphysema. Am. J. Respir. Cell Mol. Bio.
18: 670-674
[Abstract][Full Text]
Berg, C. L., Graeme-Cook, F. M.
(1997). Case 10-1997- A 68-Year-Old Woman with Hepatic Encephalopathy. NEJM
336: 939-947
[Full Text]
Lam, C. W. K., Pang, C.-P., Poon, P. M. K., Yin, C.-H., Bharathi, G.
(1997). Rapid Screening for {alpha}1-Antitrypsin Z and S Mutations,. Clin. Chem.
43: 403-404
[Full Text]
Dycaico, M., Grant, S., Felts, K, Nichols, W., Geller, S., Hager, J., Pollard, A., Kohler, S., Short, H., Jirik, F., et, al.
(1988). Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse model. Science
242: 1409-1412
[Abstract]
Teckman, J. H., Burrows, J., Hidvegi, T., Schmidt, B., Hale, P. D., Perlmutter, D. H.
(2001). The Proteasome Participates in Degradation of Mutant alpha 1-Antitrypsin Z in the Endoplasmic Reticulum of Hepatoma-derived Hepatocytes. J. Biol. Chem.
276: 44865-44872
[Abstract][Full Text]